News Daily

The Times

Australia

  • Written by The Conversation
Ivermectin was touted as a cure for COVID, now it’s being tested for cancer. But what can it actually treat?

Ivermectin was originally celebrated as a revolutionary treatment for parasitic disease in humans and animals. It has since evolved into a focal point of misinformation and heated debate.

During the early part of the COVID pandemic, it was touted on social media as a miracle cure for the virus, despite a lack of robust evidence.

Now the United States National Cancer Institute is looking into the drug as a potential cancer treatment, with early human clinical studies underway.

But what can it successfully treat?

What is ivermectin?

The drug is a small organic chemical that can be extracted from the bacterium Streptomyces avermitilis. This bacterium grows in the soil, and was first found near the grounds of a Japanese golf course.

Ivermectin’s discovery in the 1970s was considered so important its discoverers were awarded the 2015 Nobel Prize in Physiology or Medicine.

It was first approved for use in animals in 1981 and in humans in 1987. It’s now available in various brands as tablets and creams you apply to the skin.

Assessing the evidence

Governments use human clinical trials to decide whether to approve a medicine for sale.

But clinical trials aren’t the highest level of evidence to inform best practice and guide decisions. For that, there are Cochrane reviews.

A Cochrane review brings together a panel of experts who collate and assess all the relevant evidence on a medication. It takes data from multiple clinical trials, and other studies, and evaluates it following clear and structured steps. It’s able to examine and critique study designs to identify bias and reject bad data.

Cochrane reviews are also regularly updated to take into account new information. The result is a summary that is considered the highest level of evidence to guide decision-making.

So what do Cochrane reviews say about ivermectin for different conditions?

Gut and lymphatic worms

Ivermectin is used to treat a variety of parasitic worm infections. These include the round worms Ascaris lumbricoides, Strongyloides stercoralis, Wuchereria bancrofti, and Brugia malayi.

The latter two worms cause the disease lymphatic filariasis (or elephantiasis) which causes severe swelling in the arms, legs, breasts and genitals.

When ivermectin is used to treat Strongyloides stercoralis, the Cochrane panel found it is better than albendazole and had fewer side effects than thiabendazole.

For Ascaris lumbricoides, the panel concluded ivermectin was as good as albendazole and mebendazole.

For treating lymphatic filariasis, a Cochrane review found ivermectin or diethylcarbamazine should be standard treatment in combination with albendazole.

Rosacea

The Cochrane review for rosacea evaluated 22 different treatments for this skin condition, including a variety of drugs, as well as light therapy, cosmetics and reducing the intake of spicy food.

It concluded that ivermectin applied to the skin was more effective than a placebo, and a bit better than the other standard medication, metronidazole.

Scabies

Cochrane has two reviews on the use of ivermectin for scabies. One specifically evaluated ivermectin and permethrin as treatments. The other evaluated all available treatments for scabies.

The first review concluded both permethrin and ivermectin were just as effective, regardless of whether the ivermectin was administered orally or directly onto the skin.

In contrast, the second review concluded ivermectin does work but topical permethrin appeared to be the most effective treatment.

Malaria

The Cochrane panel looked specifically at whether ivermectin could reduce transmission of the malaria parasite, rather than as a treatment.

Unfortunately there was just a single clinical trial to use as evidence. In that trial, residents of eight villages were given ivermectin and albendazole together, with follow up doses of just ivermectin. The researchers then looked at the rates of child infection over 18 weeks.

Even though the trial didn’t show ivermectin prevented infection, due to the high risk of bias in it, the Cochrane panel couldn’t conclude either way whether ivermectin worked or not.

River blindness

River blindness is caused by another parasitic worm called Onchocerca volvulus.

The Cochrane review concluded there was a lack of evidence either way to know whether it works to prevent infection-based visual impairment and blindness.

It evaluated the data from four clinical trials and two large community-based studies.

One of the reasons the panel was unable to make a firm conclusion was because it thought the drug may work differently against different strains of the parasite and in people of different ethnicity.

Cancer

There are no Cochrane reviews on ivermectin’s use for cancer because clinical interest in the drug for this condition is just starting.

There is a current clinical trial that is evaluating ivermectin in combination with antibody-based drugs for breast cancer.

Early results showed the combination of antibody drugs with ivermectin was safe to patients, but no efficacy data has been published.

COVID

The Cochrane panel rejected the data for seven clinical trials and included 11 other trials. Rejected trials included those which compared ivermectin against other drugs which were known to not be effective against COVID, such as hydroxychloroquine.

The review concluded there was no evidence to support the use of ivermectin for the treatment or prevention of COVID. In making that conclusion, it evaluated treatments that used invermectin or placebo in combination with standard care and whether treatment reduced death, illness, or the length of the infection.

Read more https://theconversation.com/ivermectin-was-touted-as-a-cure-for-covid-now-its-being-tested-for-cancer-but-what-can-it-actually-treat-276180

Split Corrugated Conduit for Flexible Cable Protection

For wiring assemblies in vehicles, machinery and equipment, choosing suitable cable protection helps keep cables organised and reduces direct contact with surrounding parts. Mojak Plastics supplies plastic tubing and conduit options for different installation needs, and split corrugated conduit can... Read more

Trailers Melbourne Buyers Can Compare: When Box Trailers Make Sense

For many homeowners, businesses and tradespeople, trailers Melbourne customers use every week need to be versatile enough for changing loads. A box trailer can be particularly useful because its enclosed sides help contain cargo while providing a straightforward loading area... Read more

Bottle Label Printing That Balances Design and Readability

Product labels need to attract attention while making information easy to find and understand. On a bottle, the available space may be limited by the container’s shape, so every design decision matters. Bottle label printing should account for visual hierarchy... Read more

Office Cleaning Melbourne: Planning a Consistent Workplace Routine

Businesses looking for office cleaning Melbourne need a plan that reflects the way their workplace operates. A clean office supports day-to-day organisation, helps shared spaces remain presentable and gives employees and visitors a more orderly environment. Eco Green Cleaning Management... Read more

Pinboard Solutions for Offices, Schools and Shared Information Spaces

Why a Pinboard Remains Useful A pinboard provides a simple way to display information that needs to remain visible without being rewritten. Lawdex supplies fabric and cork options for offices, schools, staff areas and other environments. A pinboard can be used... Read more

Retractable Hose Reel: A Practical Guide To Choosing The Right Hose Storage

A retractable hose reel can make hose storage more organised, accessible and practical in workshops, commercial facilities, service areas and other working environments. Instead of leaving a hose coiled across the floor or requiring staff to manually wind it after... Read more